http://clifylq.livejournal.com/125800.html?mode=reply#add_comment
NOTE: THE FDA DID NOT APPROVE OF THIS MESSAGE AND WANTS YOU TO NOT READ IT AND STOP EATING WALNUTS OR DRINKING ANY UNPASTURIZED MILK OR ANYTHING THAT IS HEALTHY FOR YOU.
REMEMBER THEIR SLOGAN,-
“Only a drug can cure, prevent or treat a disease.”
This regulation can be understood to actually be stating: “only unnatural Allopathic substances can cure diseases.” And if you claim a natural substance can cure a disease, the FDA can, and will, shut you down.
FDA Says Walnuts Are Illegal Drugs
By William Faloon
|
|||||||
Life Extension® has
published 57 articles that describe the health benefits of walnuts.
Some of this same scientific data
is featured on the website of Diamond Foods, Inc., a distributor of
packaged walnuts.
The FDA has determined that
walnuts sold by Diamond Foods cannot be legally marketed because the walnuts
“are not generally recognized as safe and effective” for the
medical conditions referenced on Diamond Foods’ website.
According to the FDA, these
walnuts are now classified as “drugs” and the “unauthorized
health claims” cause them to become “misbranded,” thus
subjecting them to government “seizure or injunction.”
Let’s take a look at the science
supporting the consumption of walnuts to see what the FDA is up to …
and what you can do to stop it!
Eating
walnuts cuts heart disease risk
Ingesting nuts used to be
considered unhealthy because of their high fat content. This misconception
has changed over the past 17 years as human studies reveal sharply reduced
incidence of heart disease in those who consume walnuts.1-12
Unlike some nuts that contain high
levels of saturated fats, walnuts provide a unique blend of
polyunsaturated fatty acids (including omega-3s), along with nutrients
like gamma tocopherol that have demonstrated heart health
benefits.13-24
The March 4, 1993 issue of the New
England Journal of Medicine published the first clinical study
showing significant reductions in dangerous LDL and improvement in the
lipoprotein profile in response to moderate consumption of walnuts.6 Later
studies revealed that walnuts improve endothelial function in
ways that are independent of cholesterol reduction.1,25-27
One study published by the American
Heart Association on April 6, 2004 showed a 64% improvement
in a measurement of endothelial function when walnuts were substituted
for other fats in a Mediterranean diet.1
As most Life Extension
members are aware, the underlying cause of atherosclerosis is progressive endothelial
dysfunction.28 Walnuts contain a variety of nutrients including
arginine,29-33 polyphenols,34-36 and omega-3s37-42 that support the inner
arterial lining and guard against abnormal platelet aggregation. These
favorable biological effects explain why walnut consumption confers
protection against coronary artery disease.
The U.S. National Library of
Medicine database contains 35 peer-reviewed published papers supporting a
claim that ingesting walnuts improves vascular health and may reduce heart
attack risk.
FDA
ignores the science
The federal agency responsible for
protecting the health of the American public views this differently.
At the end of this editorial, we
provide a link to the FDA’s entire warning letter to Diamond Foods. Nowhere
in this bureaucratic albatross is there any discussion of the science
cited by Diamond Foods to support their health claims.
Instead, the FDA’s language
resembles that of an out-of-control police state where tyranny reins
over rationality. To enable you to recognize the absurdity of all of this, I
excerpted a few paragraphs from the FDA’s warning letter to Diamond Foods as
follows:
“Based on our review, we have
concluded that your walnut products are in violation of the Federal Food,
Drug, and Cosmetic Act (the Act) and the applicable regulations in Title 21,
Code of Federal Regulations (21 CFR).
“Based on claims made on your
firm's website, we have determined that your walnut products are promoted for
conditions that cause them to be drugs because these products are intended
for use in the prevention, mitigation, and treatment of disease.
“Because of these intended uses,
your walnut products are drugs within the meaning of section 201 (g)(1)(B) of
the Act [21 U.S.C. § 321(g)(B)]. Your walnut products are also new drugs
under section 201(p) of the Act [21 U.S.C. § 321(p)] because they are not
generally recognized as safe and effective for the above referenced
conditions. Therefore, under section 505(a) of the Act [21 U.S.C. § 355(a)],
they may not be legally marketed with the above claims in the United States
without an approved new drug application.
“Additionally, your walnut
products are offered for conditions that are not amenable to self-diagnosis
and treatment by individuals who are not medical practitioners; therefore,
adequate directions for use cannot be written so that a layperson can use these
drugs safely for their intended purposes. Thus, your walnut products are also
misbranded under section 502(f)(1) of the Act, in that the labeling for these
drugs fails to bear adequate directions for use [21 U.S.C. § 352(f)(1)].”
This verbiage makes it clear that
the FDA does not even consider the underlying science when censoring truthful
non-misleading health claims. The chilling effect on the ability of consumers
to discover lifesaving medical information is a wake up call for all who
recognize the ramifications of this latest act of FDA malfeasance.
What
the FDA allows you to hear
The number of people logging on to
the website of Diamond Foods is miniscule. I doubt that before the FDA took
this draconian action, that hardly anyone even knew this website existed.
What the public hears loud and
clear, however, are endless advertisements for artery-clogging junk foods.
Fast food chains relentlessly promote their 99 cent double-cheese burger as
being bigger than their rivals’. These advertisements induce many
consumers to salivate for these toxic calories that are a contributing
cause of coronary artery disease. Yet the FDA does not utter a peep in
suggesting that their advertising be curtailed.
On the contrary, FDA has issued
waves of warning letters to companies making foods (pomegranate juice, green
tea, and walnuts) that protect against atherosclerosis.43 The FDA is
blatantly demanding that these companies stop informing the public about the
scientifically-validated health benefits these foods provide.
The FDA obviously does not want
the public to discover that they can reduce their risk of age-related disease
by consuming healthy foods. They prefer consumers only learn about mass
marketed garbage foods that shorten life span by increasing degenerative
disease risk.
FDA
allows potato chips to be advertised as “heart healthy”
Frito-Lay® is a subsidiary of the Pepsi-Cola company.
Frito-Lay® sells $12 billion a year of products that include:
You might not associate these
mostly-fried snack foods as being good for you, but the FDA has no
problem allowing the Frito-Lay® website to state the
following:
“Frito-Lay snacks start with real
farm-grown ingredients. You might be surprised at how much good stuff
goes into your favorite snack. Good stuff like potatoes, which naturally
contain vitamin C and essential minerals. Or corn, one of the world's most
popular grains, packed with Thiamin, vitamin B6, and Phosphorous – all
necessary for healthy bones, teeth, nerves and muscles.
And it's not just the obvious
ingredients. Our all-natural sunflower, corn and soybean oils contain good
polyunsaturated and monounsaturated fats, which help lower total and LDL
“bad” cholesterol and maintain HDL “good” cholesterol levels, which can
support a healthy heart. Even salt, when eaten in moderation as part of a
balanced diet, is essential for the body.”44
Wow! Based on what Frito-Lay® is
allowed to state, it sounds like we should be living on these snacks. Who
would want to ingest walnuts, pomegranate, or green tea (which FDA now says
are illegal drugs) when these fat-calorie laden, mostly-fried carbohydrates
are so widely available?
According to the Frito Lay®
website, Lays® potato chips are now “heart healthy” because the level of saturated
fat was reduced and replaced with sunflower oil.45 Scientific
studies do show that when a polyunsaturated fat (like sunflower oil)
is substituted for saturated fat, favorable changes in blood
cholesterol occur.46
Fatally omitted from the
Frito-Lay® website is the fact that sunflower oil supplies lots of omega-6
fats, but no omega-3s.47 The American diet already contains too
many omega-6 fats and woefully inadequate omega-3.
Excess omega-6 fats in the diet in
the absence of adequate omega-3s produces devastating effects including the
production of pro-inflammatory compounds that contribute to virtually every
age-related disease including atherosclerosis.48-53
For the FDA to allow Frito-Lay® to
pretend there are heart benefits to ingesting their high-calorie snack
products, while censoring the ability of walnut companies to make
scientifically-substantiated claims, is tantamount of treason against
the health of the American public.
Don’t
forget the acrylamides
When carbohydrate foods are cooked
at high temperature (as occurs when potatoes are fried in sunflower oil to
make potato chips), a toxic compound called acrylamides is formed.54
According to the National
Cancer Institute, “acrylamide is considered to be a mutagen and a probable
human carcinogen, based mainly on studies in laboratory animals.55
Scientists do not yet know with any certainty whether the levels of
acrylamide typically found in some foods pose a health risk for humans.”
In response to these kinds of
concerns, the FDA funded a massive study to ascertain acrylamide content of
various foods. The FDA found that potato chips and other fried carbohydrate
foods were especially high in acrylamides.
The FDA, however, has not stopped
companies selling high acrylamide-containing fried carbohydrates from
promoting these foods as healthy.
Pharmaceutical
companies benefit by FDA’s misdeeds
As the aging population develops
coronary atherosclerosis, pharmaceutical companies stand to reap tens of
billions of dollars each year in profits. An obstacle standing in their way
is scientific evidence showing that a healthy diet can prevent heart disease
from developing in many people.
It is thus in the economic
interests of pharmaceutical giants that the FDA forcibly censor the ability
of companies making heart healthy foods to inform the public of the
underlying science. The fewer consumers who know the facts about walnuts,
pomegranate and green tea, the greater the demand will be for expensive
cardiac drugs.
Once again the FDA overtly
functions to enrich Big Pharma, while the public shoulders the financial
burden of today’s health-care cost crisis.
In this particular case, however, processed
food companies also stand to profit from the FDA’s attacks on healthy
foods.
FDA/FTC wants more control over what you are allowed to learn
The FDA and FTC (Federal Trade
Commission) are proposing new regulations that will stifle the ability of
natural food companies to disseminate scientific research findings.
One proposal being discussed
within the FTC would require that supplement companies conduct studies
analogous to what the FDA requires to approve new drugs. In a perfect world, Life
Extension would agree with some of the FTC’s objectives. As far as we
are concerned, the more scientific research to validate a health claim, the
better.
The reality is that natural foods
do not carry high prescription drug price markups, so it would be
economically impossible to conduct the same kinds of voluminous clinical
studies as pharmaceutical companies do. As readers of this column know, many
of the clinical studies the FDA relies on to approve new drugs are fraudulent
to begin with. So even if it were feasible to conduct more clinical research
on foods and supplements, that still does not guarantee the precise accuracy
the FTC is seeking.
If these agency proposals are
enacted, consumers will be barred from learning about new ways to protect
their health until a food or nutrient meets stringent new requirements. A
look at the warning letter the FDA sent to Diamond Foods is a frightening
example of how scientific information can be harshly censored by unelected
bureaucrats.
If anyone still thinks that
federal agencies like the FDA protect the public, this latest proclamation
that healthy foods are now illegal drugs expose the government’s
sordid charade.
Companies
that sell healthy foods try to fight back
The combined sales of the
companies attacked by the FDA is only a fraction of food giant Frito-Lay®.
Yet some of them are fighting back against the FDA’s absurd position that it
is illegal to disseminate scientific research showing the favorable effects
these foods produce in the body.
As a consumer, you should be
outraged that disease-promoting foods are protected by the federal
government, while nutritious foods are censored. There is no scientific
rationality for the FDA to do this. To the contrary, the dangerous foods ubiquitously
advertised in the media are replacing cigarettes as the leading killers in
modern society.
The federal government is heavily
lobbied by companies selling processed foods. As Life Extension revealed
long ago, an insidious activity of lobbyists is to incite federal agencies
and prosecutors to eliminate free competition in the marketplace.
Simple fact is that walnuts are
healthy to eat, while carbohydrates fried in fat are not. The FDA permits
companies selling disease-promoting foods to deceive the public, while it
suppresses the dissemination of peer-reviewed published scientific
information.
Now
the good news…
On March 23, 2010, a bipartisan
bill was introduced into the House of Representatives called the Free
Speech about Science Act (H.R. 4913). This landmark legislation protects
basic free speech rights, ends censorship of science, and enables the natural
health products community to share peer-reviewed scientific findings with the
public.
The Free Speech about Science
bill has the potential to transform medical practice by educating the public
about the real science behind natural health.
For this very reason, the bill
will have opposition. It will be opposed by the FDA since it restricts their
ability to censor the dissemination of published scientific data. It will be
opposed by drug companies fearing competition from natural health approaches
based on diet, dietary supplements, and lifestyle.
The public, on the other hand,
wants access to credible information they can use to make wise dietary
choices. Please don’t let special interests stop this bill.
I ask that each of you log on
to our Legislative
Action Website that enables you to conveniently email your
Representative to cosponsor the Free Speech about Science Act (H.R.
4913).
Passage of the Free Speech
about Science Act will stop federal agencies from squandering tax dollars
censoring what you are allowed to learn about health-promoting foods.
Our Legislative Action Website
provides you direct contact with your Representative to let them know that
you want H.R. 4913 (Free Speech about Science
Act) enacted into law. William Faloon
“When the people fear their
government, there is tyranny; when the government fears the people, there is
liberty.” – Thomas Jefferson
|
|||||||
References
|
|||||||
1 Ros E, Núñez I, Pérez-Heras A,
et al. A walnut diet improves endothelial function in hypercholesterolemic
subjects: a randomized crossover trial. Circulation. 2004 Apr
6;109(13):1609-14.
2 Feldman EB. The scientific
evidence for a beneficial health relationship between walnuts and coronary
heart disease. J Nutr. 2002 May;132(5):1062S-1101S.
3 Blomhoff R, Carlsen MH, Andersen
LF, Jacobs DR Jr. Health benefits of nuts: potential role of antioxidants. Br
J Nutr. 2006 Nov;96 Suppl 2:S52-60.
4 Mozaffarian D. Does
alpha-linolenic acid intake reduce the risk of coronary heart disease? A
review of the evidence. Altern Ther Health Med. 2005 May-Jun;11(3):24-30;
quiz 31, 79.
5 Zhao G, Etherton TD, Martin KR,
West SG, Gillies PJ, Kris-Etherton PM. Dietary alpha-linolenic acid reduces
inflammatory and lipid cardiovascular risk factors in hypercholesterolemic
men and women. J Nutr. 2004 Nov;134(11):2991-7.
6 Tapsell LC, Gillen LJ, Patch CS,
Batterham M, Owen A, Baré M, Kennedy M. Including walnuts in a
low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol
ratios in patients with type 2 diabetes. Diabetes Care. 2004
Dec;27(12):2777-83.
7 West SG. Alpha-Linolenic Acid
from Walnuts P85 and Flax Increases Flow-Mediated Dilation of the Brachial
Artery in a Dose-Dependent Fashion. Pennsylvania State University. American
Heart Association’s 5th Annual Conference on Arteriosclerosis, Thrombosis,
and Vascular Biology in San Francisco. May 2004.
8 Iwamoto M, Imaizumi K, Sato M,
Hirooka Y, Sakai K, Takeshita A, Kono M. Serum lipid profiles in Japanese
women and men during consumption of walnuts. Eur JClin Nutr. 2002
Jul;56(7):629-37.
9 Morgan JM, Horton K, Reese D, et
al. Effects of walnut consumption as part of a low-fat, low-cholesterol
diet on serum cardiovascular risk factors. Int’l J for Vit & Nutr
Research. 2002 72:341-347.
10 Hu FB, Stampfer MJ, Manson JE,
et al. Frequent nut consumption and risk of coronary heart disease in women:
prospective cohort study. BMJ. 1998 Nov 14;317(7169):1341-5.
11 Chisholm A, Mann J, Skeaff M,
et al. A diet rich in walnuts favourably influences plasma fatty acid profile
in moderately hyperlipidaemic subjects. Eur J Clin Nutr. 1998
Jan;52(1):12-6.
12 de Lorgeril M, Renaud S,
Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary
prevention of coronary heart disease. Lancet. 1994 Jun
11;343(8911):1454-9.
13 Maguire LS, O'Sullivan SM,
Galvin K, O'Connor TP, O'Brien NM. Fatty acid profile, tocopherol, squalene
and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the
macadamia nut. Int J Food Sci Nutr. 2004 May;55(3):171-8.
14 Sabaté J, Fraser GE, Burke K,
Knutsen SF, Bennett H, Lindsted KD. Effects of walnuts on serum lipid levels
and blood pressure in normal men. N Engl J Med. 1993 Mar
4;328(9):603-7.
15 Zambón D, Sabaté J, Muñoz S, et
al. Substituting walnuts for monounsaturated fat improves the serum lipid
profile of hypercholesterolemic men and women. A randomized crossover trial. Ann
Intern Med. 2000 Apr 4;132(7):538-46.
16 Iwamoto M, Imaizumi K, Sato M,
et al. Serum lipid profiles in Japanese women and men during consumption of
walnuts. Eur J Clin Nutr. 2002 Jul;56(7):629-37.
17 Simopoulos AP. Essential fatty
acids in health and chronic disease. Am J Clin Nutr. 1999 Sep;70(3
Suppl):560S-569S.
18 Hu FB, Stampfer MJ. Nut
consumption and risk of coronary heart disease: a review of epidemiologic
evidence. Curr Atheroscler Rep. 1999 Nov;1(3):204-9.
19 Zibaeenezhad MJ, Rezaiezadeh M,
Mowla A, Ayatollahi SM, Panjehshahin MR. Antihypertriglyceridemic effect of
walnut oil. Angiology. 2003 Jul-Aug;54(4):411-4.
20 Almario RU, Vonghavaravat V,
Wong R, Kasim-Karakas SE. Effects of walnut consumption on plasma fatty acids
and lipoproteins in combined hyperlipidemia. Am J Clin Nutr. 2001
Jul;74(1):72-9.
21 Anderson KJ, Teuber SS,
Gobeille A, Cremin P, Waterhouse AL, Steinberg FM. Walnut polyphenolics
inhibit in vitro human plasma and LDL oxidation. J Nutr. 2001
Nov;131(11):2837-42.
22 Singh I, Turner AH, Sinclair
AJ, Li D, Hawley JA. Effects of gamma-tocopherol supplementation on
thrombotic risk factors. Asia Pac J Clin Nutr. 2007;16(3):422-8.
23 McCarty MF. Gamma-tocopherol
may promote effective no synthase function by protecting tetrahydrobiopterin
from peroxynitrite. Med Hypotheses. 2007;69(6):1367-70.
24 Park SK, Page GP, Kim K, et al.
alpha- and gamma-Tocopherol prevent age-related transcriptional alterations
in the heart and brain of mice. J Nutr. 2008 Jun;138(6):1010-8.
25 Cortés B, Núñez I, Cofán M, et
al. Acute effects of high-fat meals enriched with walnuts or olive oil on
postprandial endothelial function. J Am Coll Cardiol. 2006 Oct
17;48(8):1666-71.
26 Ros E, Mataix J. Fatty acid
composition of nuts--implications for cardiovascular health. Br J Nutr.
2006 Nov;96 Suppl 2:S29-35.
27 Ma Y, Njike VY, Millet J, et
al. Effects of walnut consumption on endothelial function in type 2 diabetic
subjects: a randomized controlled crossover trial. Diabetes Care. 2010
Feb;33(2):227-32.
28 Brocq ML, Leslie SJ, Milliken
P, Megson IL. Endothelial dysfunction: from molecular mechanisms to
measurement, clinical implications, and therapeutic opportunities. Antioxid
Redox Signal. 2008 Sep;10(9):1631-74.
29 Wolf A, Zalpour C, Theilmeier
G, et al. Dietary L-arginine supplementation normalizes platelet aggregation
in hypercholesterolemic humans. J Am Coll Cardiol. 1997 Mar
1;29(3):479-85.
30 Miyazaki H, Matsuoka H, Cooke
JP, et al. Endogenous nitric oxide synthase inhibitor: a novel marker of
atherosclerosis. Circulation. 1999 Mar 9;99(9):1141-6.
31 Furuki K, Adachi H, Matsuoka H
et al. Plasma levels of asymmetric dimethylarginine (ADMA) are related to
intima-media thickness of the carotid artery: an epidemiological study. Atherosclerosis.
2007 Mar;191(1):206-10.
32 Dowd MB, Hemmrich K, Morrison
WA. L-arginine reduces neointimal hyperplasia in cold-stored arterial
allografts in a rabbit low-flow-through model. J Reconstr Microsurg.
2007 Aug;23(6):301-9.
33 Schini-Kerth VB, Auger C,
Kim JH, Etienne-Selloum N, Chataigneau T. Nutritional improvement of the
endothelial control of vascular tone by polyphenols: role of NO and EDHF. Pflugers
Arch. 2010 Mar 12.
34 Ristić-Medić D, Ristić G,
Tepsić V. [Alpha-linolenic acid and cardiovascular diseases]. Med Pregl.
2003 56 Suppl 1:19-25.
35 Galajda Z, Dér H, Balogh E, et
al. [Cardiovascular actions of a standardized polyphenol concentrate on
patients undergoing coronary bypass grafting: a randomized, double-blind,
placebo-controlled study]. Magy Seb. 2008 61 Suppl:41-4.
36 Kristensen SD, Iversen AM,
Schmidt EB. N-3 polyunsaturated fatty acids and coronary thrombosis. Lipids
. 2001 36:S79-S82.
37 Wensing AG, Mensink RP,
Hornstra G. Effects of dietary n-3 polyunsaturated fatty acids from plant
andmarine origin on platelet aggregation in healthy elderly subjects. Br J
Nutr. 1999 Sep;82(3):183-91.
38 De Caterina R, Cybulsky MI,
Clinton SK, Gimbrone MA Jr, Libby P. The omega-3 fatty acid docosahexaenoate
reduces cytokine-induced expression of proatherogenic and proinflammatory
proteins in human endothelial cells. Arterioscler Thromb. 1994
Nov;14(11):1829-36.
39 Available at:
http://www.nature.com/ejcn/journal/v52/n1/pdf/1600507a.pdf. Accessed April 1,
2010.
40 Freese R, Mutanen M, Valsta LM,
et al. Comparison of the effects of two diets rich in monounsaturatedfatty
acids differing in their linoleic/alpha-linolenic acid ratio on platelet
aggregation. Thrombosis &Haemostasis 1994 Jan;71(1):73-7.
41 Leaf A, Weber PC.
Cardiovascular effects of n-3 fatty acids. N Eng J Med. 1988 Mar
3;318(9):549-57.
42 Eritsland J, Arnesen H,
Seljeflot I, et al. Long-term effects of n-3 polyunsaturated fatty acids on
haemostatic variables and bleeding episodes in patients with coronary artery
disease. Blood Coagul Fibrinolysis. 1995 Feb;6(1):17-22.
43 Available at:
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm202825.htm. Accessed
March 26, 2010.
44 Available at:
http://www.fritolay.com/your-health/whats-in-our-snacks.html. March 25, 2010.
45 Available at:
http://fritolay.com/press-release-20060503.html. March 25, 2010.
46 Ródenas S, RodrÃguez-Gil S,
Merinero MC, Sánchez-Muniz FJ. Dietary exchange of an olive oil and sunflower
oil blend for extra virgin olive oil decreases the estimate cardiovascular
risk and LDL and apolipoprotein AII concentrations in postmenopausal women. J
Am Coll Nutr. 2005 Oct;24(5):361-9.
47 Quiles JL, Huertas JR, Ochoa
JJ, Battino M, Mataix J, Mañas M. Dietary fat (virgin olive oil or sunflower
oil) and physical training interactions on blood lipids in the rat. Nutrition.
2003 Apr;19(4):363-8.
48 Available at:
http://www.kedu.us/Ask%20the%20Doctor/omega%203%20cardiovascular.pdf.
Accessed March 29, 2010.
49 Chung HY, Cesari M, Anton S, et
al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing
Res Rev. 2009 Jan;8(1):18-30.
50 Simopoulos AP. The importance
of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other
chronic diseases. Exp Biol Med (Maywood). 2008 Jun;233(6):674-88.
51 Okuyama H, Kobayashi T,
Watanabe S. Dietary fatty acids--the N-6/N-3 balance and chronic elderly
diseases. Excess linoleic acid and relative N-3 deficiency syndrome seen in
Japan. Prog Lipid Res. 1996 Dec;35(4):409-57.
52 Kiecolt-Glaser JK, Belury MA,
Porter K, et al. Depressive symptoms, omega-6:omega-3 fatty acids, and
inflammation in older adults. Psychosom Med. 2007 Apr;69(3):217-24.
53 Guebre-Egziabher F,
Rabasa-Lhoret R, Bonnet F, et al. Nutritional intervention to reduce the
n-6/n-3 fatty acid ratio increases adiponectin concentration and fatty acid
oxidation in healthy subjects. Eur J Clin Nutr. 2008
Nov;62(11):1287-93.
54 Jackson LS, Al-Taher F. Effects
of consumer food preparation on acrylamide formation. Adv Exp Med Biol.
2005 561:447-65.
55 Available at:
http://www.fda.gov/Food/FoodSafety/FoodContaminantsAdulteration/ChemicalContaminants/Acrylamide/ucm053549.htm.
Accessed March 30, 2010.
clifylq http://www.clifylq.com/ |
NOTE: THE FDA DID NOT APPROVE OF THIS MESSAGE AND WANTS YOU TO NOT READ IT AND STOP EATING WALNUTS OR DRINKING ANY UNPASTURIZED MILK OR ANYTHING THAT IS HEALTHY FOR YOU.
REMEMBER THEIR SLOGAN,-
“Only a drug can cure, prevent or treat a disease.”
This regulation can be understood to actually be stating: “only unnatural Allopathic substances can cure diseases.” And if you claim a natural substance can cure a disease, the FDA can, and will, shut you down.



